Multidrug-resistant bacteria in travellers hospitalized abroad: Prevalence, characteristics, and influence on clinical outcome

Journal of Hospital Infection

Volumn 82, Issue 4, 2012, Pages 254-259

  Nemeth, J ^a   Ledergerber, B ^a   Preiswerk, B ^a   Nobile, A ^a   Karrer, S ^a   Ruef, C ^a   Kuster, S P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Clinical outcome; Colonization; Extended spectrum beta lactamase; Meticillin resistant Staphylococcus aureus; Multidrug resistance; Travellers

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; EMPORIATRICS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANCE; PREVALENCE; PROTEUS; RESPIRATORY SYSTEM; SKIN; SWITZERLAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT TRANSFER; PREVALENCE; RETROSPECTIVE STUDIES; SWITZERLAND; TRAVEL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869213296     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.08.017     Document Type: Article

References (29)

1. Hawser S.P., Bouchillon S.K., Hoban D.J., Badal R.E., Hsueh P.R., Paterson D.L. Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 2009, 53:3280-3284.
2. Diekema D.J., Pfaller M.A., Schmitz F.J., et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001, 32:S114-S132.
3. Goossens H., Ferech M., Vander Stichele R., Elseviers M., Group E.P. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:579-587.
4. Carlet J., Collignon P., Goldmann D., et al. Society's failure to protect a precious resource: antibiotics. Lancet 2011, 378:369-371.
5. Jung J.Y., Park M.S., Kim S.E., et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010, 10:228.
6. Rogers B.A., Aminzadeh Z., Hayashi Y., Paterson D.L. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 2011, 53:49-56.
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: 18th informational supplement. M100-S18 2008, CLSI, Wayne, PA.
8. Tängdén T., Cars O., Melhus A., Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010, 54:3564-3568.
9. Peirano G., Laupland K.B., Gregson D.B., Pitout J.D. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med 2011, 18:299-303.
10. Kennedy K., Collignon P. Colonisation with Escherichia coli resistant to " critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010, 29:1501-1506.
11. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9:228-236.
12. Gaynes R., Edwards J.R., System NNIS Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41:848-854.
13. Moro M., Nizzero P., Biancardi A., et al. An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy. J Hosp Infect 2008, 68:97-99.
14. Bogaerts P., Naas T., Wybo I., et al. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J Clin Microbiol 2006, 44:4189-4192.
15. Klevens R.M., Edwards J.R., Tenover F.C., et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006, 42:389-391.
16. van Duijn P.J., Dautzenberg M.J., Oostdijk E.A. Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care 2011, 17:658-665.
17. Ho J., Tambyah P.A., Paterson D.L. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010, 23:546-553.
18. Bouchillon S.K., Iredell J.R., Barkham T., Lee K., Dowzicky M.J. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Int J Antimicrob Agents 2009, 33:130-136.
19. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., Fishman N.O. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001, 32:1162-1171.
20. Du B., Long Y., Liu H., et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002, 28:1718-1723.
21. Kim Y.K., Pai H., Lee H.J., et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002, 46:1481-1491.
22. Peña C., Pujol M., Ardanuy C., et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J Hosp Infect 2001, 47:53-59.
23. Sunenshine R.H., Wright M.O., Maragakis L.L., et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007, 13:97-103.
24. Magret M., Lisboa T., Martin-Loeches I., et al. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study. Crit Care 2011, 15:R62.
25. Garnacho J., Sole-Violan J., Sa-Borges M., Diaz E., Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 2003, 31:2478-2482.
26. Eberle B.M., Schnüriger B., Putty B., et al. The impact of Acinetobacter baumannii infections on outcome in trauma patients: a matched cohort study. Crit Care Med 2010, 38:2133-2138.
27. Stelfox H.T., Bates D.W., Redelmeier D.A. Safety of patients isolated for infection control. JAMA 2003, 290:1899-1905.
28. Niven D.J., Laupland K.B., Gregson D.B., Church D.L., Group SaSI Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill. J Crit Care 2009, 24:583-589.
29. Pujol M., Peña C., Pallares R., et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996, 100:509-516.